ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityNo recent work listed
Percy David Papa Akuetteh
Matched on ORCID iD 0000-0003-0444-2351; OpenAlex author ID A5087986121. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2020: 1 paper · 2021: none · 2022: 3 papers
Papers 4
- Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. Co-author DOI 10.1002/jbt.23192↗
- Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. Co-author DOI 10.1038/s41416-022-02002-2↗
- A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-022-02562-6↗
- STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation. Co-author DOI 10.3389/fonc.2020.594224↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shijia Wu · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in p… DOI 10.1186/s12935-022-02562-6↗
- Huimin Huang · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in p… DOI 10.1186/s12935-022-02562-6↗
- Guihua Jin · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in p… DOI 10.1186/s12935-022-02562-6↗
- Linhua Lan · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in p… DOI 10.1186/s12935-022-02562-6↗
- Hongbao Yang · 2 shared papers, 2020–2022 · strength 0.26
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53… DOI 10.3389/fonc.2020.594224↗
- Qiyu Zhang · 2 shared papers, 2020–2022 · strength 0.26
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53… DOI 10.3389/fonc.2020.594224↗
- Chunmei Wen · 1 shared paper, 2022 · strength 0.16
- Xiang Zhou · 1 shared paper, 2022 · strength 0.16
- Jie Deng · 1 shared paper, 2022 · strength 0.16
- Zheng Xu · 1 shared paper, 2022 · strength 0.16
- Qingqing Ruan · 1 shared paper, 2022 · strength 0.16
- Fugen Shangguan · 1 shared paper, 2022 · strength 0.15
- Wenqian Huang · 1 shared paper, 2020 · strength 0.11
- Chenlei Zheng · 1 shared paper, 2020 · strength 0.11
- Keqing Shi · 1 shared paper, 2020 · strength 0.11
- Bicheng Chen · 1 shared paper, 2020 · strength 0.11
- Shanshan Hu · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.